Neuropathy Screening


Showing the single result

  • Request Quotation


    Facilitating accurate and timely detection of
    Diabetic Neuropathy in your patients

    Diabetic peripheral neuropathy (DPN) is among the top ten diseases that pose heavy burdens on patients and clinicians.

     85% of amputation cases due to diabetic peripheral neuropathy can be avoided with earlier detection.

    Optimally managing diabetic foot disease has been a challenge to clinicians for many years, due to its complex multifactorial aetiology and lack of adequate tools to study the underlying pathology.

    • Nearly 50% of individuals with diabetes will develop peripheral neuropathy during their lifetime.
    • Peripheral neuropathy increases the risk for diabetic foot ulcers and amputations.
    • Vibration perception threshold (VPT) testing is a clinically validated method for early neuropathy detection.


    VibraSense Screening

    VibraSense – Peripheral Neuropathy Screening Device

    Rated 0 out of 5
    Read more
    About This Item